1. Home
  2. LEGN vs SARO Comparison

LEGN vs SARO Comparison

Compare LEGN & SARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • SARO
  • Stock Information
  • Founded
  • LEGN 2014
  • SARO 1911
  • Country
  • LEGN United States
  • SARO United States
  • Employees
  • LEGN N/A
  • SARO N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • SARO
  • Sector
  • LEGN Health Care
  • SARO
  • Exchange
  • LEGN Nasdaq
  • SARO NYSE
  • Market Cap
  • LEGN 7.0B
  • SARO 9.3B
  • IPO Year
  • LEGN 2020
  • SARO 2024
  • Fundamental
  • Price
  • LEGN $27.78
  • SARO $29.96
  • Analyst Decision
  • LEGN Strong Buy
  • SARO Buy
  • Analyst Count
  • LEGN 13
  • SARO 8
  • Target Price
  • LEGN $75.67
  • SARO $34.75
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • SARO 1.7M
  • Earning Date
  • LEGN 05-13-2025
  • SARO 05-12-2025
  • Dividend Yield
  • LEGN N/A
  • SARO N/A
  • EPS Growth
  • LEGN N/A
  • SARO N/A
  • EPS
  • LEGN N/A
  • SARO 0.23
  • Revenue
  • LEGN $728,303,000.00
  • SARO $5,437,026,000.00
  • Revenue This Year
  • LEGN $65.96
  • SARO $14.74
  • Revenue Next Year
  • LEGN $52.55
  • SARO $11.20
  • P/E Ratio
  • LEGN N/A
  • SARO $127.51
  • Revenue Growth
  • LEGN 112.46
  • SARO 17.03
  • 52 Week Low
  • LEGN $29.27
  • SARO $21.31
  • 52 Week High
  • LEGN $60.87
  • SARO $34.38
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.61
  • SARO N/A
  • Support Level
  • LEGN $30.25
  • SARO N/A
  • Resistance Level
  • LEGN $33.30
  • SARO N/A
  • Average True Range (ATR)
  • LEGN 1.78
  • SARO 0.00
  • MACD
  • LEGN -0.57
  • SARO 0.00
  • Stochastic Oscillator
  • LEGN 5.19
  • SARO 0.00

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About SARO STANDARDAERO INC.

StandardAero Inc is a provider of aftermarket services for fixed and rotary wing aircraft gas turbine engines and auxiliary power units (APUs) to the commercial, business, and military aircraft markets. It also provides aftermarket and upgrade services for business aviation and helicopter airframes and avionics. It operates in two segments Engine Services and Component Repair Services. The group generates the majority of its revenue from the Engine Services segment which provides engine and airframe maintenance, repair, overhaul, and related services to customers in the Commercial Aerospace, Military & Helicopter, and Business Aviation end markets.

Share on Social Networks: